Lehman biotech veteran to advise Global Life Science Ventures

Frederick Frank, a veteran biotech banker from Lehman Brothers, will act as an adviser to Global Life Science Ventures, the Munich-based venture capital firm, on developing portfolio companies bought from its new €143m ($162m) fund.

Frank, who became a partner at Lehman in 1969, will continue as a director and vice-chairman of the bank's US-based biotechnology investment banking division.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump